Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

DTC Restrictions Ahead: Risk Management Plans, “Drug Watch” Are Vehicles

Jun 13 2005

• By The Pink Sheet

Related Content

FDA Urges Greater Compliance With Ad Submission Regulations

Jun 06 2005

FDA Ad Warning Letters On Track For Significant Increase In 2005

May 16 2005

FDA Rx Safety Website Will Include Drugs With Emerging Off-Label Issues

May 09 2005

J&J To Promote Dapoxetine With “Responsible” DTC Campaign

May 30 2005

Amylin Agrees To Symlin Marketing Restrictions In Gaining FDA Approval

Mar 21 2005

Pfizer Tells Doctors To Consider COX-2 Alternatives; DTC Ads Are Halted

Jan 03 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window